Researchers created a nanofibrous scaffold to see how it supports cell growth.

Mar 7, 2018

The Scientist Staff, The Scientist Staff

Researchers at the Moscow Institute of Physics and Technology (MIPT) created a 3-D model of synthetic nanofibers to learn how to engineer more efficient scaffolds for biomedical applications. The researchers reported in Acta Biomaterialia last week (March 2) that cardiac muscle cells, called cardiomyocytes, interface with nanofibers differently than do fibroblasts—connective tissue cells.

“[W]e discovered that during their development on a nanofibrous scaffold, cardiomyocytes wrap the fibers on all sides creating a ‘sheath’ structure in the majority of cases,” says study coauthor Konstantin Agladze, a physicist at MIPT, in a press release. “Fibroblasts, by contrast, have a more rigid structure and a much smaller area of interaction with the substrate, touching it only on one side.” This finding could help scientists engineer more effective nanofiber scaffolds for “smart” biomaterials, the researchers write in the study.

Lentiviruses are powerful tools in molecular biology. Download this eBook to learn about the basics of lentivirus preparation and production, working with lentiviruses, and counting and storing lentiviruses.

Is precision your middle name when it comes to pipetting, or is your technique more elementary? Find out with this poster from The Scientist and Thermo Fisher Scientific!

Learn about how scientists use the presence of biomarker molecules, released when cellular or tissue integrity has been compromised, to detect and gauge neurological injury with this poster from The Scientist and Quanterix!

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.